AU2574197A - Dhea combination therapy - Google Patents
Dhea combination therapyInfo
- Publication number
- AU2574197A AU2574197A AU25741/97A AU2574197A AU2574197A AU 2574197 A AU2574197 A AU 2574197A AU 25741/97 A AU25741/97 A AU 25741/97A AU 2574197 A AU2574197 A AU 2574197A AU 2574197 A AU2574197 A AU 2574197A
- Authority
- AU
- Australia
- Prior art keywords
- combination therapy
- dhea
- dhea combination
- therapy
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002648 combination therapy Methods 0.000 title 1
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1569596P | 1996-04-17 | 1996-04-17 | |
US60/015695 | 1996-04-17 | ||
PCT/IB1997/000414 WO1997038695A1 (en) | 1996-04-17 | 1997-04-17 | Dhea combination therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2574197A true AU2574197A (en) | 1997-11-07 |
AU734807B2 AU734807B2 (en) | 2001-06-21 |
Family
ID=21773003
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU25741/97A Ceased AU734807B2 (en) | 1996-04-17 | 1997-04-17 | Dhea combination therapy |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0901375A1 (en) |
JP (1) | JP2000508654A (en) |
KR (1) | KR20000005539A (en) |
CN (1) | CN1216470A (en) |
AU (1) | AU734807B2 (en) |
CA (1) | CA2251733A1 (en) |
IL (1) | IL126623A0 (en) |
NO (1) | NO984851L (en) |
WO (1) | WO1997038695A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU776853B2 (en) * | 1998-11-24 | 2004-09-23 | Harbor Biosciences, Inc. | Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of malaria and the treatment of African and American Trypanosomiasis |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6667299B1 (en) | 2000-03-16 | 2003-12-23 | Hollis-Eden Pharmaceuticals, Inc. | Pharmaceutical compositions and treatment methods |
EP1133287A2 (en) * | 1998-11-24 | 2001-09-19 | Hollis-Eden Pharmaceuticals Inc. | Use of 17-ketosteroids for the treatment of hepatitis c virus and other togaviruses |
WO2000032176A2 (en) * | 1998-11-27 | 2000-06-08 | Hollis-Eden Pharmaceuticals, Inc. | Use of 17-ketosteroids for the treatment of toxoplasmosis and cryptosporidosis |
WO2014166501A2 (en) * | 2013-04-10 | 2014-10-16 | Skau Aps | Use of immune suppressive peptides as adjuvants |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3815472A1 (en) * | 1988-05-06 | 1989-11-16 | Centre Regional De Transfusion | MONOCLONAL ANTICOERPER AND ITS USE |
IE882585L (en) * | 1988-08-25 | 1990-02-25 | Prendergast Patrick T | Viral treatment system |
IL94878A (en) * | 1989-06-28 | 2003-01-12 | Schering Corp | Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same |
US5231012A (en) * | 1989-06-28 | 1993-07-27 | Schering Corporation | Nucleic acids encoding cytokine synthesis inhibitory factor (interleukin-10) |
HU220103B (en) * | 1992-08-20 | 2001-10-28 | Schering-Plough Corp. | New application of IL-10 |
US5449688A (en) * | 1993-03-30 | 1995-09-12 | The United States Of America As Represented By The Department Of Health And Human Services | Method of treating chronic inflammatory diseases |
-
1997
- 1997-04-17 IL IL12662397A patent/IL126623A0/en unknown
- 1997-04-17 CA CA002251733A patent/CA2251733A1/en not_active Abandoned
- 1997-04-17 CN CN97193912A patent/CN1216470A/en active Pending
- 1997-04-17 KR KR1019980708339A patent/KR20000005539A/en not_active Withdrawn
- 1997-04-17 AU AU25741/97A patent/AU734807B2/en not_active Ceased
- 1997-04-17 WO PCT/IB1997/000414 patent/WO1997038695A1/en not_active Application Discontinuation
- 1997-04-17 JP JP9536909A patent/JP2000508654A/en active Pending
- 1997-04-17 EP EP97917365A patent/EP0901375A1/en not_active Withdrawn
-
1998
- 1998-10-16 NO NO984851A patent/NO984851L/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU776853B2 (en) * | 1998-11-24 | 2004-09-23 | Harbor Biosciences, Inc. | Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of malaria and the treatment of African and American Trypanosomiasis |
Also Published As
Publication number | Publication date |
---|---|
CN1216470A (en) | 1999-05-12 |
NO984851D0 (en) | 1998-10-16 |
EP0901375A1 (en) | 1999-03-17 |
NO984851L (en) | 1998-12-17 |
WO1997038695A1 (en) | 1997-10-23 |
KR20000005539A (en) | 2000-01-25 |
CA2251733A1 (en) | 1997-10-23 |
JP2000508654A (en) | 2000-07-11 |
AU734807B2 (en) | 2001-06-21 |
IL126623A0 (en) | 1999-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU690054B2 (en) | Earmuff-eyeglass combination | |
AUPO203996A0 (en) | Therapeutic uses | |
AP2002002661A0 (en) | Combination therapy for oesteoporosis | |
AU4578297A (en) | New combination | |
AU2784397A (en) | Contrast agents | |
AU3645397A (en) | Anticancer agents | |
AU3701397A (en) | Anti-herpesviral agent | |
AUPO434196A0 (en) | An improved therapeutic | |
AU4636396A (en) | Antiglucocorticoid medicament | |
AU3130597A (en) | Tristetraprolin | |
AU2547895A (en) | Therapeutic phenoxyalkylheterocycles | |
AU2574197A (en) | Dhea combination therapy | |
AU7623898A (en) | Tri-pocket | |
AU5330198A (en) | Therapeutic compounds | |
AU1643797A (en) | Repeater-system | |
AU3395795A (en) | Anchorage | |
AU5897998A (en) | 5-oxoprolinase | |
AUPO314896A0 (en) | Therapeutic agent | |
AU3978697A (en) | Plasmin-depletion therapy | |
AU1644297A (en) | Improved eyewear-earplug combination | |
AU3389797A (en) | Phosphocholinate cardenolides | |
AUPO860297A0 (en) | Therapeutic combination | |
AUPO181796A0 (en) | Therapeutic uses | |
AU2003200183A1 (en) | Cholestrol-lowering Therapy | |
AUPO203596A0 (en) | Hormone therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) | ||
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |